Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
Neurology
•
Neuromuscular
Do patients on eculizumab or ravulizumab require repeat vaccination against meningococcal infection after a certain interval?
Answer from: at Academic Institution
Yes, CDC recommends a booster Men B vaccine 1 year after completion of series and then every 2-3 years thereafter, and booster Men C every 5 years.
Sign in or Register to read more
16983
Related Questions
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
How do you counsel newly diagnosed patients with ALS on dietary recommendations?
How do you identify patients with false positive AcHR antibodies?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How do you counsel patients with ALS on the benefits of enteral nutrition?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
What postural change in FVC is suggestive of respiratory muscle weakness?
What typical lab tests do you send off for evaluation of neuropathy?
Do you recommend routine neurosyphilis testing in patients being evaluated for dementia?
What workup do you recommend for patients with symptoms suggestive of saphenous neuropathy?